A study published in Scientific Reports found that first-time users of psychoactive brew ayahuasca showed decreases in psychopathology and depression one month and six months later.
The study authors sampled first-time and regular users of the psychedelic substance. Researchers recruited 40 subjects who were soon to attend their first ayahuasca ceremony. The drop in depression scores now reached statistical significance. Click to read full story: https://www.psypost.org/2020/08/psychedelic-brew-ayahuasca-produces-therapeutic-benefits-lasting-up-to-six-months-57748?utm_source=rss&utm_medium=rss&utm_campaign=psychedelic-brew-ayahuasca-produces-therapeutic-benefits-lasting-up-to-six-monthsThe researchers express that understanding the risks and benefits of ayahuasca use is crucial, pointing out that although adverse effects were generally not found in their study, “some secondary acute reactions were observed in some individual cases (e.g. anxiety).”
TheraCann International is actively engaged in the development of new technologies and clinical trials that proof the efficacy and benefits of psychedelics. Ask us more – email@example.com